Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts
17/6 00:01
During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30......